SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-066907
Filing Date
2021-05-14
Accepted
2021-05-14 16:31:37
Documents
99
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210331x10q.htm   iXBRL 10-Q 1433792
2 EXHIBIT 31.1 tmb-20210331xex31d1.htm EX-31.1 9784
3 EXHIBIT 31.2 tmb-20210331xex31d2.htm EX-31.2 9935
4 EXHIBIT 32 tmb-20210331xex32.htm EX-32 7561
  Complete submission text file 0001104659-21-066907.txt   7651173

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210331.xsd EX-101.SCH 93943
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210331_cal.xml EX-101.CAL 64029
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210331_def.xml EX-101.DEF 211777
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210331_lab.xml EX-101.LAB 606872
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210331_pre.xml EX-101.PRE 454432
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210331x10q_htm.xml XML 1319999
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 21925192
SIC: 2834 Pharmaceutical Preparations